TARGETING MMPS AND ADAMTSS IN OSTEOARTHRITIS  by Nagase, H.
C2 Abstracts from Invited Speakers
insertional sites of ligaments and muscles, the outer third of the
menisci and, possibly, the synovium but their role is uncertain.
Reported structural correlates of OA pain include the association
between knee pain and minimal cartilage lesions, alterations in
patellar cartilage volume, osteophytes, bone marrow edema, joint
effusion and synovial thickening, and periarticular lesions includ-
ing bursitis and iliotibial band syndrome. However, a controversy
about each of the reported structural correlates remains:
Cartilage. Prior studies demonstrate a poor association between
knee pain and cartilaginous defects. Only a few studies demon-
strate an association between the two. One of them states that
most symptoms are found in patients with grade IIa cartilage
lesions. They hypotisized that clinical symptoms are most sub-
stantial at the onset of OA, when cartilage defects occur.
Osteophytes. Some studies demonstrate an association between
osteophytes and knee pain. They associate OA pain with an
osteophyte located in the patellofemoral compartment, at the
inferior pale of the patella, at the medial tibial plateau, or when
more than four osteophytes anywhere in the knee were present.
An association between central osteophytes and knee stiffness,
but not knee pain, was suggested in yet two other studies.
Bone marrow edema. The role of BME in OA is controversial,
as contradictory results have been reported. BME have been
associated with clinical symptoms in patients with OA in several
studies. BME is associated with progression of OA as assessed
by joint space narrowing on conventional radiographs. On the
other hand, other studies report no association between BME
and clinical symptoms, or with progression of disease.
Joint effusion. In the literature a controversy exists about the
association between joint effusion and knee pain. Some studies
ﬁnds that moderate and severe effusions (grade 2 and 3) were
signiﬁcantly more common among those with knee pain com-
pared to those without in patients with knee OA, others don’t.
An explanation for the association between pain and joint effu-
sion is given in different studies by the suggestion that capsular
distention is the cause of knee pain.
Baker’s cysts. No association was found between the presence
or grade of a Baker’s cysts and clinical features. Popliteal cysts
are as common in patients with knee pain as in those without.
Meniscal tears. No association was found between meniscal
tears in patients with OA and clinical features.
The fact that most structural correlates of OA pain are contro-
versial is important with regards to future clinical trials, as it
urges conservatism with regards to the idea of a single struc-
tural feature being an outcome measure for progression of the
disease. A further quest to identify ideal parameters to quantify
the progression of the disease, and ﬁnd a structural correlate of
OA pain, is needed.
TARGETING MMPS AND ADAMTSS IN OSTEOARTHRITIS
H. Nagase
Imperial College London, London, United Kingdom
Purpose: Degradation of the cartilage matrix seriously impairs
the function of joints. The primary cause of this process is ele-
vated levels of proteolytic enzymes; primarily collagenases which
are members of the matrix metalloproteinase (MMP) family, and
aggrecanases that belong to the related family of metallopro-
teinases with disintegrin and thrombospondin motifs (ADAMTSs).
Synthetic inhibitors of these metalloproteinases are therefore po-
tential therapeutic agents, but those with a zinc-chelating moiety
directed against the active site showed serious side effects in
clinical trials, possibly due to lack of selectivity. With the aim of
developing new types of inhibitors, we have been investigating
the mechanism of action of collagenases and aggrecanases and
engineered more selective variants of the tissue inhibitors of
metalloproteinases (TIMPs).
Methods: Mutagenesis-based structural and functional stud-
ies of MMP-1 (collagenase 1), ADAMTS-4 (aggrecanase 1),
ADAMTS-5 (aggrecanase 2) and TIMP-3; Molecular modelling;
Pig cartilage explant culture to analyze cartilage degradation
in vitro and enzyme inhibition kinetics to investigate the mode
of action of calcium pentosan polysulfate (CaPPS) as a car-
tilage protectant; OA model induced by meniscotibial ligament
transection using transgenic mice over-expressing TIMP-3 or its
aggrecanase-selective mutant.
Results: Typical collagenases consist of a catalytic domain and
a hemopexin (Hpx) domain that are connected by a linker region.
Using MMP-1 we have shown that collagenase locally unwinds
triple helical collagen before it hydrolyzes the peptide bonds and
this reaction requires cooperativity of the catalytic and Hpx do-
mains. Mutagenesis studies suggested that the putative collagen
binding-site is created by both the catalytic and the Hpx domains.
This potential collagen binding groove is partially blocked by the
pro-domain in the zymogen of MMP-1 (proMMP-1) and may be
a suitable site to target with an exosite inhibitor.
Domain deletion mutagenesis studies of ADAMTS-4 and
ADAMTS-5 indicated that the non-catalytic domains of the ag-
grecanases play pivotal roles in substrate recognition and aggre-
canolysis. CaPPS inhibits the aggrecanase activity of ADAMTS-4
and ADAMTS-5 as an exosite inhibitor by interacting with their
non-catalytic domains. When added to cartilage, CaPPS binds
to TIMP-3 secreted by chondrocytes and blocks LDL receptor-
related protein (LRP)-mediated internalization of TIMP-3. This
accumulates TIMP-3 in the cartilage and the CaPPS-bound
TIMP-3 is a much more effective inhibitor of ADAMTS-4 and
ADAMTS-5, but not of MMPs.
We engineered TIMP-3 mutants [(-1Ala)N-TIMP-3, (-2Ala-Ala)N-
TIMP-3 and N-TIMP-3(T2G)] that inhibit ADAMTS-4 and -5, but
not MMPs. Over-expression of either the wild-type TIMP-3 or
(-1Ala)TIMP-3 in transgenic mouse cartilage prevented cartilage
degradation in a surgically-induced OA model.
Conclusions: Highly selective inhibitors are required for suc-
cessful metalloproteinase inhibitor therapy of OA.
Structural and functional studies of collagenases and two aggre-
canases indicate that inhibitors that interact with the non-catalytic
domains of these multidomain metalloproteinases will achieve
selectivity.
CaPPS is a unique exosite inhibitor of aggrecanases. In cartilage,
it exhibits three modes of action to block aggrecan breakdown.
Protection of cartilage from degradation in an OA mouse model
by over-expressing an aggrecanase-selective TIMP-3 variant
suggests that aggrecanase may be a good target for therapeutic
intervention in OA.
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The mature articular chondrocyte embedded in the cartilage ma-
trix is a resting cell with no detectable mitotic activity and very
low synthetic activity. As the single cellular constituent of adult
articular cartilage, chondrocytes are responsible for maintaining
the cartilage matrix in a low turnover state of equilibrium. Since
chondrocyte metabolism in situ occurs in low oxygen tension and
is remote from a vascular supply, it is not surprising that changes
in expression of cartilage matrix constituents occur in isolated
chondrocytes in monolayer culture, where they increase syn-
thetic activity by several orders of magnitude. Primary cultures
have provided useful models for studying cellular responses to
alterations in the environment such as those occurring in different
forms of arthritis. Nevertheless, the source of the cartilage cannot
